SCHEMBL21438902

SCHEMBL21438902

O=C(O)NCc1cccc(-c2nc(CO)nn3cccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.38
▸ BRD4 O60885 6/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ PDK1 Q15118 1/20 0.35
▸ WDR5 P61964 1/20 0.35
▸ LIPG Q9Y5X9 1/20 0.35
▸ ASAH1 Q13510 1/20 0.35
▸ CARM1 Q86X55 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21438976 0.86 PDK1 (0.48) AOC3BRD4CNR2CYP1A2CYP2D6
SCHEMBL21545173 0.85 BRD4 (0.47) BRD4CYP1A2CYP2D6
SCHEMBL21438953 0.80 CFD (0.47) AOC3BRD4CNR2CYP1A2CYP2D6
SCHEMBL21438491 0.79 BRD4 (0.40) BRD4CNR2CYP1A2CYP2D6CYP2C9
SCHEMBL21438911 0.73 BRD4 (0.47) BRD4CYP1A2CYP2D6CYP2C9
SCHEMBL21455897 0.72 BRD4 (0.47) BRD4CYP1A2CYP2D6PDK1
SCHEMBL16396868 0.71 AOC3 (0.58) AOC3CNR2CYP1A2CYP2D6CYP2C9
SCHEMBL21438042 0.71 AVPR1B (0.39) —
SCHEMBL16396753 0.68 AOC3 (0.45) AOC3CYP1A2CYP2D6CYP2C9TSHR
SCHEMBL3368486 0.67 TSHR (0.59) AOC3CYP1A2CYP2D6CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3687506-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2020-08-05 — — EP disclosed
WO-2019195720-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2019-10-10 — — WO disclosed
Send feedback